Nursing homework assistance

2

Running head: End-Stage Renal Disease

Annotated Bibliography: End Stage Renal Disease

Tionette Kirk-Banks

Charles R. Drew University of Medicine and Science

NUR 621: Advanced Nursing Theory

Dr. Gail Burmeister, DNP PMHNP-BC, APRN, RN

August 6, 2025

Introduction

End-Stage Renal Disease (ESRD) represents the final, irreversible stage of chronic kidney disease (CKD), in which kidney function declines to less than 15% of normal capacity. At this point, life-sustaining interventions such as dialysis or kidney transplantation become essential for survival. According to the Centers for Disease Control and Prevention (CDC, 2023), more than 785,000 Americans are living with ESRD, a figure projected to rise due to increasing rates of diabetes and hypertension. Beyond the profound physiological toll, ESRD exerts a significant psychological burden on affected individuals. The illness disrupts daily routines, social relationships, financial stability, and personal autonomy, often leading to emotional distress, isolation, and despair (Hedayati & Suri, 2021).

Depression and anxiety are especially prevalent in this population, with estimates suggesting that nearly one-third of dialysis patients meet clinical criteria for depressive disorders (Cukor & Cohen, 2020). These mental health concerns are not just secondary to chronic illness, they interact dynamically with physical health, influencing treatment adherence, symptom burden, and overall outcomes. For instance, individuals with untreated depression are more likely to miss dialysis appointments, decline dietary recommendations, and experience higher hospitalization rates (Hedayati & Suri, 2021). Therefore, psychological distress in ESRD is not merely a comorbidity, it is a core component of disease management.

Contemporary Cognitive Behavioral Theory (CBT), as outlined in Beck and Dozois’s (2020) Generic Cognitive Model, provides a structured, evidence-based framework for understanding and intervening in the maladaptive thought patterns and behaviors commonly observed in individuals with ESRD. CBT posits that distorted cognitions such as hopelessness, catastrophizing, or feelings of worthlessness drive emotional distress and behavioral dysfunction. By identifying and restructuring these cognitions, patients can improve mood, regain a sense of agency, and increase engagement in health-promoting behaviors.

This paper will explore the experience of ESRD through the lens of contemporary CBT, integrating relevant health and mental health theories, examining underlying neurobiological mechanisms, considering sociocultural diversity factors, and outlining effective treatment strategies. A holistic, biopsychosocial approach is necessary to address the multifaceted challenges faced by this vulnerable population.

Description of End-Stage Renal Disease (ESRD)

End-Stage Renal Disease (ESRD) represents the final stage of chronic kidney disease (CKD), in which kidney function declines to less than 15% of normal capacity. At this advanced stage, the kidneys can no longer adequately filter metabolic waste, maintain fluid and electrolyte balance, or regulate blood pressure without renal replacement therapy—typically dialysis or transplantation. Symptoms often include profound fatigue, edema, nausea, pruritus, difficulty concentrating, and shortness of breath due to fluid overload. Additionally, many patients report sleep disturbances, sexual dysfunction, and cognitive decline, further compounding the physical burden of illness (Hedayati & Suri, 2021).

The emotional and psychological toll of ESRD is equally significant. The Centers for Disease Control and Prevention (CDC, 2023) reports that over 785,000 Americans are currently living with ESRD, and projections indicate that this number will continue to rise, fueled by the increasing prevalence of diabetes and hypertension two leading causes of kidney failure. Racial and ethnic disparities persist in ESRD prevalence, with Black and Hispanic Americans more likely to progress to ESRD compared to their White counterparts, often due to inequitable access to preventive care, delayed referrals to nephrology services, and social determinants of health (CDC, 2023).

Living with ESRD requires extensive lifestyle changes and commitment to a demanding treatment regimen, often involving dialysis multiple times per week for several hours per session. This process can disrupt employment, strain relationships, and contribute to social withdrawal and financial hardship. As a result, many patients develop feelings of helplessness, grief, and emotional exhaustion. Depression and anxiety are prevalent, yet often underdiagnosed, in the ESRD population (Cukor & Cohen, 2020). These psychological symptoms can negatively affect treatment adherence and health-related quality of life.

Importantly, the loss of autonomy associated with chronic dialysis can lead to existential distress. Patients frequently express frustration over their dependence on machines or caregivers, which may foster a sense of diminished personal agency and self-worth (Hedayati & Suri, 2021). Without integrated psychological support, such experiences can culminate in a cycle of emotional decline, poor treatment engagement, and worsened clinical outcomes. Therefore, understanding ESRD as both a medical and psychosocial condition is essential for comprehensive patient care.

Application of Contemporary Cognitive Behavioral Theory

Contemporary Cognitive Behavioral Theory (CBT), rooted in the foundational work of Aaron Beck and expanded to include neurobiological insights, offers a powerful framework for understanding and treating psychological distress in End-Stage Renal Disease (ESRD) (Beck & Dozois, 2020). Negative automatic thoughts such as 'I’m a burden to my family' contribute significantly to emotional suffering and disengagement (Cukor & Cohen, 2020).

Two common diagnoses frequently encountered in this population are Major Depressive Disorder and Generalized Anxiety Disorder. CBT addresses these issues by helping patients identify cognitive distortions, such as catastrophizing, all-or-nothing thinking, and overgeneralization. These distortions are systematically challenged through cognitive restructuring. Patients are taught to monitor and reevaluate their thoughts using tools such as thought logs, behavioral experiments, and Socratic questioning. Behavioral interventions, including activity scheduling, behavioral activation, and problem-solving training, are used to reintroduce meaning and structure into daily life (Beck & Dozois, 2020).

In advanced practice, these concepts translate into measurable, patient-centered goals. For example, Goal 1: The patient will identify and reframe at least three negative automatic thoughts per week using a CBT thought record over the next four weeks. Goal 2: The patient will engage in one meaningful activity (e.g., a phone call with a friend, a short walk, or journaling) at least three times per week for one month. Evidence-based therapeutic interventions include weekly individual CBT sessions (in-person or via telehealth), the use of a CBT-based self-help workbook tailored for chronic illness, and integration of brief mindfulness exercises to improve emotional regulation (Beck & Dozois, 2020; Hedayati & Suri, 2021).

Kernberg’s Object Relations Theory has sufficient pragmatic adequacy for application in advanced practice, especially in settings involving chronic illness and emotional complexity, such as ESRD care, psychotherapy, and integrated behavioral health. While the theory requires more time and psychodynamic expertise, its principles are clinically useful for understanding emotional regulation, dependency, and patient-provider relationships (Caligor et al., 2022).

Although the theory itself is qualitative, empirical indicators such as the PHQ-9, GAD-7, and Defense Style Questionnaire (DSQ) can be used to measure symptom improvement and therapeutic progress (Zimmermann et al., 2019).

The theory is best suited for long-term mental health settings, chronic disease care, and relationally complex patients. It is less appropriate for acute care, emergency settings, or patients with severe cognitive impairments, where brief, structured therapies like CBT are more effective (Caligor et al., 2022).

Overview of Selected Theory: Kernberg’s Object Relations Theory

Kernberg’s Object Relations Theory, an extension of psychoanalytic theory, emphasizes the development of the self through early relational experiences and the internalization of significant others. This theory is particularly concerned with how individuals form internal representations—or "objects"—of self and others, which influence personality development, emotional regulation, and interpersonal functioning throughout life (Kernberg, 2020).

Assumptions of the theory include the belief that early relationships are internalized and shape personality structure, that psychological development involves resolving conflicts between opposing object representations (good vs. bad), and that psychopathology arises when these representations are inadequately integrated. Major concepts include object representations, ego functions, defense mechanisms, and identity integration. These are dynamically linked—fragmented or negative internal objects can impair emotional regulation and identity cohesion (Caligor et al., 2022).

This theory is justified in ESRD care because chronic illness often reactivates unresolved early dependency, fear of abandonment, and feelings of helplessness. ESRD patients undergoing dialysis or facing life-altering procedures often struggle with issues related to control, self-worth, and relational vulnerability, making Kernberg’s model particularly relevant for understanding and addressing emotional dysregulation in these settings (Kernberg, 2020; Caligor et al., 2022).

Evaluation

Kernberg’s Object Relations Theory has moderate pragmatic adequacy. While highly insightful and useful for understanding emotionally complex cases, the abstract nature of the theory and its psychodynamic language can present barriers to practical applications, especially in fast-paced or acute care settings. The theory requires advanced training in psychoanalytic approaches and is best suited for long-term, insight-oriented therapy settings (Kernberg, 2020).

Although less applicable in time-limited interventions, its principles enhance interdisciplinary care by helping clinicians recognize transference, resistance, and relational patterns that influence treatment engagement. Empirical measurement tools like the PHQ-9 and GAD-7 can be integrated to assess emotional symptoms, but direct empirical validation of object relations constructs remains limited (Caligor, Kernberg, & Clarkin, 2022).

The theory is most appropriate in psychotherapy, behavioral health integration, and chronic illness settings such as ESRD, where emotional regression, dependency, and identity disruption are prevalent. It is less suitable for emergency, acute, or high-volume clinical environments that prioritize short-term stabilization (Kernberg, 2020; Caligor et al., 2022).

Health and Mental Health Integration

The relationship between physical illness and mental health in End-Stage Renal Disease (ESRD) is deeply intertwined and bidirectional, meaning that mental health significantly influences physical outcomes, and vice versa (Hedayati & Suri, 2021). Depression is one of the most common comorbidities in patients with ESRD, and its presence is strongly associated with poorer clinical outcomes, including decreased adherence to dialysis regimens, dietary noncompliance, increased hospitalization rates, and even higher mortality (Cukor & Cohen, 2020; Kimmel & Peterson, 2020). Thus, integrating mental health care within the broader treatment paradigm of ESRD is essential for improving both psychological well-being and physiological stability.

The Health Belief Model (HBM) offers a valuable framework for understanding how patients with ESRD perceive their illness and engage in self-management. According to HBM, a patient's likelihood of adhering to treatment is influenced by their perceived severity of the condition, perceived benefits of action, perceived barriers, and cues to action. For example, a patient who views dialysis as life-sustaining and perceives benefit in dietary restrictions is more likely to comply with treatment, particularly when supported by consistent reinforcement from providers (Beck & Dozois, 2020).

The Theory of Reasoned Action further explains how attitudes and social norms influence health-related behavior. If a patient believes that significant others (e.g., family, caregivers, healthcare providers) expect adherence to treatment and values their opinion, they are more likely to comply. Conversely, patients who internalize stigma or experience cultural or religious conflict related to illness and dependency may develop feelings of hopelessness or resistance to care (Kimmel & Peterson, 2020). These barriers are particularly pronounced in marginalized populations, where gaps in health literacy and historical mistrust in medical institutions can further impede engagement (Cukor & Cohen, 2020).

Integrating mental health services directly into nephrology settings—such as routine screening for depression, access to counseling, and psychoeducational resources—provides a more holistic, patient-centered approach. Embedding licensed clinical social workers, psychologists, or psychiatric nurse practitioners in dialysis centers or outpatient nephrology clinics helps normalize mental health care, improve communication across specialties, and reduce fragmentation of services (Hedayati & Suri, 2021).

Ultimately, acknowledging and addressing the psychological dimensions of ESRD care is not merely supplementary—it is foundational to improving quality of life and long-term outcomes for this vulnerable population (Beck & Dozois, 2020; Centers for Disease Control and Prevention [CDC], 2023).

Neurobiology

End-Stage Renal Disease (ESRD) has significant neurobiological implications. Uremic toxins, which accumulate in the bloodstream due to impaired kidney function, can cross the blood-brain barrier and negatively affect cognitive processes and mood regulation (Hedayati & Suri, 2021). Patients frequently report symptoms such as memory loss, difficulty concentrating, and mood disturbances (Kimmel & Peterson, 2020).

Chronic stress associated with ESRD activates the hypothalamic-pituitary-adrenal (HPA) axis, leading to elevated cortisol levels, which further compromise immune functioning and disrupt neurotransmitter systems (Cukor & Cohen, 2020). Neurobiological studies indicate that depression in ESRD patients is linked to dysregulation of key neurotransmitters, including serotonin, dopamine, and norepinephrine, all of which play essential roles in emotional regulation (Hedayati & Suri, 2021).

Furthermore, systemic inflammation and oxidative stress—both prevalent in ESRD—contribute to the neurobiological pathogenesis of depression and anxiety in this population (Cukor & Cohen, 2020). These findings underscore the importance of integrating neurobiological insights into psychotherapeutic approaches and tailoring interventions such as Cognitive Behavioral Therapy (CBT) to address both emotional and physiological dimensions of illness (Beck & Dozois, 2020).

Diversity Considerations

Diversity factors significantly shape the experience, progression, and treatment of End-Stage Renal Disease (ESRD). African Americans are nearly three times more likely than White individuals to develop ESRD, largely due to higher prevalence of hypertension and diabetes, as well as systemic barriers to preventive care and early intervention (Centers for Disease Control and Prevention [CDC], 2023). Socioeconomic status further impacts disease management; individuals from low-income backgrounds often encounter difficulties accessing consistent dialysis, mental health care, transportation, and nutritious food (Cukor & Cohen, 2020).

Gender disparities also play a role—women with ESRD are more likely to report depressive symptoms, while men are generally less likely to seek psychological support due to stigma or social conditioning (Hedayati & Suri, 2021). Cultural beliefs about illness, mental health, and dependence on medical systems may influence patients’ willingness to disclose symptoms or pursue therapy. Language barriers can further complicate communication, reduce trust in providers, and impair health literacy (Cukor & Cohen, 2020).

A culturally competent approach is essential for addressing these disparities. This includes using interpreters, understanding cultural attitudes toward illness, tailoring communication strategies, and recognizing how race, gender, income, and language intersect to shape the ESRD experience (Hedayati & Suri, 2021; Kimmel & Peterson, 2020).

Treatment

Effective treatment of ESRD-related psychological distress requires a multidisciplinary approach (Cukor & Cohen, 2020). CBT offers a structured, evidence-based method for addressing depression and anxiety in this population (Beck & Dozois, 2020). Cognitive restructuring techniques help patients identify and challenge negative thoughts related to illness and disability (Hedayati & Suri, 2021). Behavioral activation encourages re-engagement with meaningful activities, combatting the lethargy and isolation common in ESRD (Cukor & Cohen, 2020). Mindfulness and stress reduction techniques can help patients manage uncertainty and improve emotional regulation (Beck & Dozois, 2020). Pharmacological interventions, such as selective serotonin reuptake inhibitors (SSRIs), may be appropriate for patients with moderate to severe depression (Hedayati & Suri, 2021). Collaboration among nephrologists, nurses, social workers, and mental health professionals ensures comprehensive care (Kimmel & Peterson, 2020). Psychoeducation, support groups, and telehealth options can also enhance access and adherence, especially in underserved communities (CDC, 2023).

In expanding treatment strategies for ESRD-related psychological distress, individualized and sustained intervention plans are critical. Building upon cognitive behavioral therapy (CBT), the Generic Cognitive Model proposed by Beck and Dozois (2020) emphasizes that dysfunctional thinking patterns underpin emotional and behavioral disturbances. Within the ESRD population, distorted cognitions may include catastrophes about prognosis, internalizing shame due to dependence on dialysis, or hopelessness regarding future health. By targeting these cognitive distortions through structured CBT protocols, providers can support patients in reframing maladaptive thoughts and developing more realistic and empowering beliefs about their illness.

Behavioral activation remains a cornerstone for managing depression in this population, as it directly counters inactivity and withdrawal, which are common in patients undergoing dialysis several times per week (Cukor & Cohen, 2020). Encouraging patients to re-engage in pleasurable and socially meaningful activities even in limited or adapted forms has been shown to reduce depressive symptoms and enhance quality of life. Simple interventions like scheduled phone calls with family, participation in spiritual or community activities, or developing new hobbies can yield significant emotional benefits.

Pharmacological management may be warranted for patients with moderate to severe depressive symptoms. Selective serotonin reuptake inhibitors (SSRIs), such as sertraline or citalopram, are generally well-tolerated in ESRD patients, although close monitoring of side effects and drug interactions is essential due to altered renal metabolism (Hedayati & Suri, 2021). Providers should also be mindful of overlapping somatic symptoms between depression and uremia, which can complicate accurate diagnosis and treatment response assessment.

Furthermore, effective care for ESRD-related mental health distress requires coordinated interdisciplinary collaboration. Involvement of nephrologists, nurses, social workers, and mental health professionals promotes consistent psychosocial monitoring, reduces fragmentation of care, and fosters trust (Kimmel & Peterson, 2020). Psychoeducation, whether delivered in person or via telehealth, can enhance patients’ understanding of their condition and empower them to actively engage in both their medical and psychological care (CDC, 2023).

Finally, support groups, either peer-led or professionally facilitated, offer a safe space for emotional expression and normalization of shared experiences. These groups may reduce isolation and improve coping among patients managing the psychosocial burden of ESRD (Cukor & Cohen, 2020).

Conclusion

End-Stage Renal Disease presents profound challenges that extend beyond physical health, encompassing significant psychological and social dimensions (Kimmel & Peterson, 2020). Contemporary Cognitive Behavioral Theory provides a valuable framework for understanding and addressing the mental health needs of ESRD patients (Beck & Dozois, 2020). By integrating cognitive restructuring, behavioral activation, neurobiological insights, and culturally informed care, clinicians can offer holistic and effective treatment (Hedayati & Suri, 2021). Addressing the mind-body connection is essential for improving quality of life and health outcomes in this vulnerable population (Cukor & Cohen, 2020).

References

Beck, A. T., & Dozois, D. J. A. (2020). Cognitive therapy: Current status and future directions.

Annual Review of Medicine, 71, 1–16. https://doi.org/10.1146/annurev-med-070918-020621

Centers for Disease Control and Prevention. (2023). Chronic kidney disease in the United States,

2023. https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.html

Cukor, D., & Cohen, S. D. (2020). Mental health in chronic kidney disease and dialysis:

Challenges and opportunities. Nature Reviews Nephrology, 16(8), 477–490.

https://doi.org/10.1038/s41581-020-0282-y

Hedayati, S. S., & Suri, R. S. (2021). Depression in chronic kidney disease: Current

epidemiology and treatment. Kidney International Supplements, 11(2), 222–229.

https://doi.org/10.1016/j.kisu.2021.06.003

Kernberg, O. F. (2020). Object relations theory and its clinical applications: A contemporary

perspective. Journal of the American Psychoanalytic Association, 68(2), 321–344.

https://doi.org/10.1177/0003065120918343

Kimmel, P. L., & Peterson, R. A. (2020). Depression in patients with chronic kidney disease: The

last 10 years. Kidney International, 97(6), 1104–1114.

https://doi.org/10.1016/j.kint.2020.01.034